Annual Accounts Payable
$5.62 M
+$1.76 M+45.57%
December 31, 2023
Summary
- As of February 10, 2025, ONTX annual accounts payable is $5.62 million, with the most recent change of +$1.76 million (+45.57%) on December 31, 2023.
- During the last 3 years, ONTX annual accounts payable has risen by +$786.00 thousand (+16.26%).
Performance
ONTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$6.57 M
+$949.00 K+16.89%
March 31, 2024
Summary
- As of February 10, 2025, ONTX quarterly accounts payable is $6.57 million, with the most recent change of +$949.00 thousand (+16.89%) on March 31, 2024.
- Over the past year, ONTX quarterly accounts payable has increased by +$949.00 thousand (+16.89%).
Performance
ONTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ONTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.6% | +16.9% |
| 3 y3 years | +16.3% | +16.9% |
| 5 y5 years | +39.1% | +16.9% |
ONTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -50.9% | at high | -58.0% |
| 5 y | 5-year | at high | -50.9% | at high | -58.0% |
| alltime | all time | -9.2% | -50.9% | -6.6% | -58.0% |
Onconova Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $6.57 M(+16.9%) |
| Dec 2023 | $5.62 M(+45.6%) | $5.62 M(-8.6%) |
| Sep 2023 | - | $6.15 M(+21.2%) |
| Jun 2023 | - | $5.07 M(+3.6%) |
| Mar 2023 | - | $4.90 M(+26.8%) |
| Dec 2022 | $3.86 M(+40.0%) | $3.86 M(+2.7%) |
| Sep 2022 | - | $3.76 M(+25.2%) |
| Jun 2022 | - | $3.00 M(-3.8%) |
| Mar 2022 | - | $3.12 M(+13.2%) |
| Dec 2021 | $2.76 M(-43.0%) | $2.76 M(-31.9%) |
| Sep 2021 | - | $4.05 M(-5.6%) |
| Jun 2021 | - | $4.29 M(+7.6%) |
| Mar 2021 | - | $3.99 M(-17.5%) |
| Dec 2020 | $4.83 M(+13.2%) | $4.83 M(-15.6%) |
| Sep 2020 | - | $5.72 M(+11.2%) |
| Jun 2020 | - | $5.15 M(+23.1%) |
| Mar 2020 | - | $4.18 M(-2.1%) |
| Dec 2019 | $4.27 M(+5.7%) | $4.27 M(-5.6%) |
| Sep 2019 | - | $4.52 M(-4.8%) |
| Jun 2019 | - | $4.75 M(+9.6%) |
| Mar 2019 | - | $4.33 M(+7.3%) |
| Dec 2018 | $4.04 M | $4.04 M(-5.3%) |
| Sep 2018 | - | $4.26 M(-28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $5.95 M(-15.4%) |
| Mar 2018 | - | $7.03 M(+13.7%) |
| Dec 2017 | $6.19 M(+16.2%) | $6.19 M(+13.8%) |
| Sep 2017 | - | $5.44 M(-4.3%) |
| Jun 2017 | - | $5.68 M(+5.1%) |
| Mar 2017 | - | $5.41 M(+1.6%) |
| Dec 2016 | $5.32 M(+55.6%) | $5.32 M(+30.8%) |
| Sep 2016 | - | $4.07 M(+45.3%) |
| Jun 2016 | - | $2.80 M(-15.0%) |
| Mar 2016 | - | $3.30 M(-3.7%) |
| Dec 2015 | $3.42 M(-15.0%) | $3.42 M(+7.2%) |
| Sep 2015 | - | $3.19 M(-23.8%) |
| Jun 2015 | - | $4.18 M(+8.5%) |
| Mar 2015 | - | $3.86 M(-4.2%) |
| Dec 2014 | $4.03 M(+8.5%) | $4.03 M(-25.2%) |
| Sep 2014 | - | $5.38 M(+7.1%) |
| Jun 2014 | - | $5.03 M(+52.2%) |
| Mar 2014 | - | $3.30 M(-11.0%) |
| Dec 2013 | $3.71 M(-32.8%) | $3.71 M(-15.8%) |
| Sep 2013 | - | $4.41 M(-0.1%) |
| Jun 2013 | - | $4.41 M(+3.9%) |
| Mar 2013 | - | $4.24 M(-23.1%) |
| Dec 2012 | $5.52 M(-1.7%) | $5.52 M |
| Dec 2011 | $5.61 M | - |
FAQ
- What is Onconova Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Onconova Therapeutics?
- What is Onconova Therapeutics annual accounts payable year-on-year change?
- What is Onconova Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly accounts payable year-on-year change?
What is Onconova Therapeutics annual accounts payable?
The current annual accounts payable of ONTX is $5.62 M
What is the all time high annual accounts payable for Onconova Therapeutics?
Onconova Therapeutics all-time high annual accounts payable is $6.19 M
What is Onconova Therapeutics annual accounts payable year-on-year change?
Over the past year, ONTX annual accounts payable has changed by +$1.76 M (+45.57%)
What is Onconova Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ONTX is $6.57 M
What is the all time high quarterly accounts payable for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly accounts payable is $7.03 M
What is Onconova Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ONTX quarterly accounts payable has changed by +$949.00 K (+16.89%)